Anti-α-galactosyl antibodies recognizing epitopes terminating with α1,4-linked galactose: Human natural and mouse monoclonal anti-NOR and anti-P1 antibodies

Glycobiology

Volumn 15, Issue 2, 2005, Pages 109-118

  Duk, Maria ^a   Kusnierz Alejska, Grazyna ^b   Korchagina, Elena Y ^c   Bovin, Nicolai V ^c   Bochenek, Stanislawa ^d   Lisowska, Elwira ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d Reg Center for Blood Transfusion   (Poland)

Author keywords

Anti NOR; Anti P1; Anti galactosyl; Glycolipids; Polyagglutination

Indexed keywords

GALACTOSYL ANTIBODY; GLYCAN; GLYCOLIPID; GLYCOSPHINGOLIPID; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; NUCLEOLUS ORGANIZER REGION MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; PEPTIDE 1 ANTIBODY; PEPTIDE ANTIBODY; PROTEIN ANTIBODY; TRISACCHARIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CHROMOSOME NOR; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMAGGLUTINATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNODIFFUSION; NONHUMAN; PRIORITY JOURNAL;

PAA;

EID: 13644263675     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.glycob.a034964     Document Type: Article

References (25)

1. Bovin, N.V. (1998) Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj. J., 15, 431-446.
2. Buonomano, R., Tinguely, C., Rieben, R., Mohacsi, P.J., and Nydegger, U.E. (1999) Quantitation and characterization of anti-Galα1-3Gal antibodies in sera of 200 healthy subjects. Xenotrans., 5, 173-180.
3. D'Alessandro, M., Mariani, P., Lomanto, D., Bachetoni, A., and Speranza, V. (2002) Alterations in serum anti-α-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis. Clin. Immunol., 103, 63-68.
4. Davis, B.G., Chambers, D., Cumpsley, I., France, R., and Gamblin, D. (2003) Synthesis and activation of carbohydrate donors: acetates, halides, phenyl selenides and glycals. In Osborn, H.M.I. (Ed.), Best synthetic methods: carbohydrates. Academic Press, Oxford, pp. 69-120.
5. Duk, M., Reinhold, B.B., Reinhold, V.N., Kusnierz-Alejska, G., and Lisowska, E. (2001) Structure of a neutral glycosphingolipid recognized by human antibodies in polyagglutinable erythrocytes of the rare NOR phenotype. J. Biol. Chem., 276, 40574-40582.
6. Duk, M., Westerlind, U., Norberg, T., Pazynina, G., Bovin, N.V., and Lisowska E. (2003a) Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-α-galactosyl antibodies. Glycobiology, 13, 279-284.
7. Duk, M., Reinhold, B.B., Reinhold, V.N., and Lisowska E. (2003b) Unusual glycosphingolipids in polyagglutinable NOR erythrocytes. Abstracts of XVII International Symposium on Glycoconjugates, Bangalore 2003, p. 38.
8. Galili, U. (2001) The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie, 83 557-563.
9. Galili, U., Ishida, H., Tanabe, K., and Toma, H. (2002) Anti-gal A/B, a novel anti blood group antibody identified in recipients of abo-incompatible kidney allografts. Transplantation, 74, 1574-1580.
10. Harris, P.A., Roman, G.K., Moulds, J.J., Bird, G.W.G., and Shah, N.G. (1982) An inherited RBC characteristic, NOR, resulting in erythrocyte polyagglutination. Vox Sang., 42, 134-140.
11. Iwamura, K., Furukawa, K., Uchikawa, M., Sojka, B.N., Kojima, Y., Wiels, J., Shiku, H., Urano, T., and Furukawa, K. (2003) The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle. J. Biol. Chem., 278, 44429-44438.
12. Kallin, E. (1994) Use of glycosylamines in preparation of oligosaccharide polyacrylamide copolymers. Methods Enzymol., 242 (A), 221-226.
13. Kallin, E., Lönn, H., Norberg, T., and Elofsson, M. (1989) Derivatization procedures for reducing oligosaccharides. 3. Preparation of oligosaccharide glycosylamines and their conversion into oligosaccharide-acrylamide copolymers. J. Carbohydr. Chem., 8 597-611.
14. Knobel, M., Umezawa, E.S., Cardia, M.S., Martins, M.J.T., Correa, M.L.C., Gianella-Neto, D., Caulier, C., and Medeiros-Neto, G. (1999) Elevated anti-α-galactosyl antibody titers in endemic goiter. Thyroid, 9, 493-498.
15. a glycophorin in one family. Relation of NOR polyagglutination to terminal α-galactose residues and abnormal glycolipids. Transfusion 39, 32-38.
16. Lisowska, E. and Duk, M. (2004) Polyagglutination NOR: new glycosphingolipid antigens recognized by a new type of common human anti-α-galactosyl antibodies. Arch. Biochem. Biophys., 426, 142-147.
17. Ouchterlony, O. (1958) Diffusion-in-gel methods for immunological analysis. Prog. Allergy, 5, 1-78.
18. Reid, M.E. and Lomas-Francis, C. (1997) The blood group antigens. Facts book. Academic Press, San Diego.
19. Rieben, R., Bovin, N.V., Korchagina, E.Y., Oriol, R., Nifant'ev, N.E., Tsvetskov, D.E., Daha, M.R., Mohacsi, P.J., and Jozassie, D.H. (2000) Xenotransplantation: in vitro analysis of synthetic α-galactosyl inhibitors of human anti-Galα1-3Gal IgM and IgG antibodies. Glycobiology, 10, 141-148.
20. Romanowska, A., Meunier, S.J., Tropper, F.D., Lafferriere, C.A., and Roy, R. (1994) Michael additions for syntheses of neoglycoproteins. Methods Enzymol., 242(A), 90-101.
21. Siebert, H.C., Andre, S., Lu, S-Y., Frank, M., Kaltner, H., van Kuik, J.A., Korchagina, E.Y., Bovin, N., Tajkhorshid, E., Kaptein, R., and others. (2003) Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry, 42, 14762-14773.
22. Vaultier, M., Knouzi N., and Carrié, R. (1983), Reduction d'azides en amines primaires par une methode generale utilisant la reaction de Staudinger. Tetrahedron Lett., 24, 763-764.
23. Westerlind, U., Hagback, P., Duk, M., and Norberg, T. (2002) Synthesis and inhibitory activity of a di- and a trisaccharide corresponding to an erythrocyte glycolipid responsible for the NOR polyagglutination. Carbohydr. Res., 337, 1517-1522.
24. Wieslander, J., Mansson, O., Kallin, E., Gabrielli, A., Novack, H., and Timpl, R. (1990) Specificity of human antibodies against Galα1-3Gal carbohydrate epitope and distinction from natural antibodies reacting with Galα1-2Gal or Galα1-4Gal. Glycoconj. J., 7, 85-100.
25. Winand, R.J., Winand-Devigne, J., Meurisse M., and Galili, U. (1994) Specific stimulation of of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. J. Immunol., 153, 1386-1395.